MedTrace Logo

Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia

NCT02343497 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2018-01-09

No results posted yet for this study

Summary

The purpose of this study is to investigate whether astaxanthin supplementation can impact triglyceride plasmatic concentrations in volunteers presenting mild dyslipidemia.

Conditions

  • Dyslipidemias

Interventions

DIETARY_SUPPLEMENT

Astaxanthin

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Institut Polytechnique LaSalle Beauvais

    collaborator OTHER

  • Naturalpha

    collaborator INDUSTRY

  • Ajinomoto Foods Europe SAS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-09-30
Completion
2015-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02343497 on ClinicalTrials.gov